Genome-Wide Association Study of Beta-Blocker Survival Benefit in Black and White Patients with Heart Failure with Reduced Ejection Fraction.

导出 OA

翻译打印收藏纠错

作者： Jasmine A,Luzum ^[1] ; Alessandra M,Campos-Staffico ^[2] ; Jia,Li ^[1] ; Ruicong,She ^[3] ; Hongsheng,Gui ^[3] ; Edward L,Peterson ^[2] ; Bin,Liu ^[3] ; Hani N,Sabbah ^[3] ; Mark P,Donahue ^[4] ; William E,Kraus ^[5] ; L Keoki,Williams ^[5] ; David E,Lanfear ^[2]

作者单位： Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, MI 48109, USA. ^[1] Center for Individualized and Genomic Medicine Research (CIGMA), Henry Ford Health System, Detroit, MI 48202, USA. ^[2] Department of Public Health Sciences, Henry Ford Health System, Detroit, MI 48202, USA. ^[3] Heart and Vascular Institute, Henry Ford Health System, Detroit, MI 48202, USA. ^[4] School of Medicine, Duke University, Durham, NC 27710, USA. ^[5]

关键词 beta-blocker genome-wide association study heart failure with reduced ejection fraction survival

主题词人类(Humans);肾上腺素能β受体拮抗剂(Adrenergic beta-Antagonists);全基因组关联研究(Genome-Wide Association Study);心力衰竭(Heart Failure);前瞻性研究(Prospective Studies);每搏输出量(Stroke Volume);心室功能障碍, 左(Ventricular Dysfunction, Left)

DOI 10.3390/genes14112019

PMID 38002962

发布时间 2024-06-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交